Takashi Nakaoku

Druggable Oncogene Fusions in Invasive Mucinous Lung Adenocarcinoma

Takashi Nakaoku, Koji Tsuta, Hitoshi Ichikawa et al. · Clinical Cancer Research · 2014 · 218 citations

Medicine, Genetics, Oncology +17

A secondary RET mutation in the activation loop conferring resistance to vandetanib

Takashi Nakaoku, Takashi Kohno, Mitsugu Araki et al. · Nature Communications · 2018 · 106 citations · Full text

Medicine, Molecular Biology, Oncology +15

Oncogenic Fusion Gene <i>CD74-NRG1</i> Confers Cancer Stem Cell–like Properties in Lung Cancer through a IGF2 Autocrine/Paracrine Circuit

Takahiko Murayama, Takashi Nakaoku, Masato Enari et al. · Cancer Research · 2016 · 66 citations

Medicine, Cell Biology, Oncology +17

High-Dose Crizotinib for Brain Metastases Refractory to Standard-Dose Crizotinib

Young Hak Kim, Hiroaki Ozasa, Hiroki Nagai et al. · Journal of Thoracic Oncology · 2013 · 39 citations · Full text

Medicine, Oncology, Pharmacology +11

An Oncogenic <i>ALK</i> Fusion and an <i>RRAS</i> Mutation in <i>KRAS</i> Mutation-Negative Pancreatic Ductal Adenocarcinoma

Yoko Shimada, Takashi Kohno, Hideki Ueno et al. · The Oncologist · 2017 · 28 citations · Full text

Medicine, Molecular Biology, Oncology +17